Prostaglandins F, Synthetic
"Prostaglandins F, Synthetic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Analogs or derivatives of prostaglandins F that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGF.
| Descriptor ID |
D011461
|
| MeSH Number(s) |
D10.251.355.255.550.775.500 D23.469.050.175.725.775.500 D23.469.700.670
|
| Concept/Terms |
Prostaglandins F, Synthetic- Prostaglandins F, Synthetic
- PGF Synthetic
- Synthetic, PGF
- Prostaglandin F Analogues
- Analogues, Prostaglandin F
- Prostaglandin F Analogs
- Analogs, Prostaglandin F
- Synthetic Prostaglandins F
|
Below are MeSH descriptors whose meaning is more general than "Prostaglandins F, Synthetic".
Below are MeSH descriptors whose meaning is more specific than "Prostaglandins F, Synthetic".
This graph shows the total number of publications written about "Prostaglandins F, Synthetic" by people in this website by year, and whether "Prostaglandins F, Synthetic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prostaglandins F, Synthetic" by people in Profiles.
-
Wong JC, Shiuey EJ, Razeghinejad R, Shukla AG, Kolomeyer NN, Myers JS, Pro MJ, Lee D. The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma center. Graefes Arch Clin Exp Ophthalmol. 2023 Jan; 261(1):193-200.
-
Mehran NA, Sinha S, Razeghinejad R. New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost. Eye (Lond). 2020 01; 34(1):72-88.
-
Rabinowitz MP, Katz LJ, Moster MR, Myers JS, Pro MJ, Spaeth GL, Sharma P, Stefanyszyn MA. Unilateral Prostaglandin-Associated Periorbitopathy: A Syndrome Involving Upper Eyelid Retraction Distinguishable From the Aging Sunken Eyelid. Ophthalmic Plast Reconstr Surg. 2015 Sep-Oct; 31(5):373-8.
-
Ichhpujani P, Katz LJ, Hollo G, Shields CL, Shields JA, Marr B, Eagle R, Alvim H, Wizov SS, Acheampong A, Chen J, Wheeler LA. Comparison of human ocular distribution of bimatoprost and latanoprost. J Ocul Pharmacol Ther. 2012 Apr; 28(2):134-45.
-
Jay Katz L, Myers JS. Smoothing the intraocular pressure roller coaster: a new goal? Am J Ophthalmol. 2009 Aug; 148(2):177-8.
-
Bayer A, Henderer JD, Kwak T, Myers J, Fontanarosa J, Spaeth GL. Clinical predictors of latanoprost treatment effect. J Glaucoma. 2005 Aug; 14(4):260-3.
-
Sudesh S, Cohen EJ, Rapuano CJ, Wilson RP. Corneal toxicity associated with latanoprost. Arch Ophthalmol. 1999 Apr; 117(4):539-40.